Literature DB >> 16185739

The poxviral scrapin MV-LAP requires a myxoma viral infection context to efficiently downregulate MHC-I molecules.

Nicolas Collin1, Jean-Luc Guérin, Ingo Drexler, Sophie Blanié, Jacqueline Gelfi, Séverine Boullier, Gilles Foucras, Gerd Sutter, Frédérique Messud-Petit.   

Abstract

Downregulation of MHC class I molecules is a strategy developed by some viruses to escape cellular immune responses. Myxoma virus (MV), a poxvirus causing rabbit myxomatosis, encodes MV-LAP that is known to increase MHC-I endocytosis and degradation through a C(4)HC(3) motif critical for an E3 ubiquitin ligase activity. Here, we performed a functional mapping of MV-LAP and showed that not only the C(4)HC(3) motif is necessary for a marked downregulation of MHC-I but also a conserved region in the C-terminal part of the protein. We also showed that the putative transmembrane domains are responsible for a specific subcellular localization of the protein: they retain MV-LAP in the ER in transfected cells and in the endolysosomal compartments in infected cells. We observed that a specific MV infection context is necessary for a fully efficient downregulation of MHC-I. Our data suggest that the functionality of viral LAP factors, inherited by herpes- and poxviruses from mammalian cells, is more complex than anticipated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16185739     DOI: 10.1016/j.virol.2005.07.032

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

Review 1.  Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions.

Authors:  Joana Loureiro; Hidde L Ploegh
Journal:  Adv Immunol       Date:  2006       Impact factor: 3.543

2.  Punctuated Evolution of Myxoma Virus: Rapid and Disjunct Evolution of a Recent Viral Lineage in Australia.

Authors:  Peter J Kerr; John-Sebastian Eden; Francesca Di Giallonardo; David Peacock; June Liu; Tanja Strive; Andrew F Read; Edward C Holmes
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

3.  Genome scale evolution of myxoma virus reveals host-pathogen adaptation and rapid geographic spread.

Authors:  Peter J Kerr; Matthew B Rogers; Adam Fitch; Jay V Depasse; Isabella M Cattadori; Alan C Twaddle; Peter J Hudson; David C Tscharke; Andrew F Read; Edward C Holmes; Elodie Ghedin
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

4.  Reverse Engineering Field Isolates of Myxoma Virus Demonstrates that Some Gene Disruptions or Losses of Function Do Not Explain Virulence Changes Observed in the Field.

Authors:  June Liu; Isabella M Cattadori; Derek G Sim; John-Sebastian Eden; Edward C Holmes; Andrew F Read; Peter J Kerr
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

Review 5.  What has the study of the K3 and K5 viral ubiquitin E3 ligases taught us about ubiquitin-mediated receptor regulation?

Authors:  Jessica M Boname; Paul J Lehner
Journal:  Viruses       Date:  2011-01-28       Impact factor: 5.818

6.  Evolutionary history and attenuation of myxoma virus on two continents.

Authors:  Peter J Kerr; Elodie Ghedin; Jay V DePasse; Adam Fitch; Isabella M Cattadori; Peter J Hudson; David C Tscharke; Andrew F Read; Edward C Holmes
Journal:  PLoS Pathog       Date:  2012-10-04       Impact factor: 6.823

Review 7.  Myxoma virus and the Leporipoxviruses: an evolutionary paradigm.

Authors:  Peter J Kerr; June Liu; Isabella Cattadori; Elodie Ghedin; Andrew F Read; Edward C Holmes
Journal:  Viruses       Date:  2015-03-06       Impact factor: 5.048

8.  Genomic and phenotypic characterization of myxoma virus from Great Britain reveals multiple evolutionary pathways distinct from those in Australia.

Authors:  Peter J Kerr; Isabella M Cattadori; Matthew B Rogers; Adam Fitch; Adam Geber; June Liu; Derek G Sim; Brian Boag; John-Sebastian Eden; Elodie Ghedin; Andrew F Read; Edward C Holmes
Journal:  PLoS Pathog       Date:  2017-03-02       Impact factor: 6.823

9.  Myxoma virus infection promotes NK lysis of malignant gliomas in vitro and in vivo.

Authors:  Henry Ogbomo; Franz J Zemp; Xueqing Lun; Jiqing Zhang; Danuta Stack; Masmudur M Rahman; Grant McFadden; Christopher H Mody; Peter A Forsyth
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.